Azitra (AZTR) Other Non-Current Liabilities (2022 - 2025)
Azitra (AZTR) reported Other Non-Current Liabilities of $51.0 for Q3 2025, down 88.84% on a YoY basis from $457.0 in Q3 2024, and down 72.28% quarter-over-quarter from $184.0 in Q2 2025.
Azitra (AZTR) Other Non-Current Liabilities (2022 - 2025) Analysis & Trends
Azitra has reported Other Non-Current Liabilities for 4 years, with the latest figure at $51.0 in Q3 2025.
- For the quarter ending Q3 2025, Other Non-Current Liabilities fell 88.84% year-over-year to $51.0; the trailing twelve-month figure through Sep 2025 stood at $51.0 (down 88.84% YoY), and the FY2024 full-year result was $381.0, down 98.93% from the prior year.
- Other Non-Current Liabilities for Q3 2025 stood at $51.0, down from $184.0 in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $158994.0 in Q2 2023, with the low at $51.0 in Q3 2025.
- Historically, Other Non-Current Liabilities has averaged $30654.4 across 4 years, with a median of $2926.0 in 2024.
- Annual changes were most pronounced in 2023 — Other Non-Current Liabilities sank 49.56% — and 2024, when it plunged 99.25%.
- Azitra's Other Non-Current Liabilities stood at $70283.0 in 2022, then slumped by 49.56% to $35453.0 in 2023, then slumped by 98.93% to $381.0 in 2024, then sank by 86.61% to $51.0 in 2025.
- The last three Other Non-Current Liabilities figures came in at $51.0 (Q3 2025), $184.0 (Q2 2025), and $238.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Azitra | 20,900.00 | 20,900.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 51.00 |
| Jun 30, 2025 | 184.00 |
| Mar 31, 2025 | 238.00 |
| Dec 31, 2024 | 381.00 |
| Sep 30, 2024 | 457.00 |
| Jun 30, 2024 | 2,926.00 |
| Mar 31, 2024 | 7,298.00 |
| Dec 31, 2023 | 35,453.00 |
| Sep 30, 2023 | 60,933.00 |
| Jun 30, 2023 | 158,994.00 |
| Dec 31, 2022 | 70,283.00 |